Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,827.20
(
-0.49%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.70
(
-1.04%
)
Bitcoin
75,196.06
(
1.81%
)
News Focus
News Focus
Post# of 821995
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 308
Posts 37286
Boards Moderated 1
Alias Born 11/14/2013

flipper44

Member Level

Re: iclight post# 212725

Monday, 02/04/2019 5:18:33 PM

Monday, February 04, 2019 5:18:33 PM

Post# of 821995
That-was-IMUC's-phase-I-16-patient-trial-ICI. Unblinded.

You are literally comparing a phase III blinded trial (DCVax-L) to a phase I unblinded (aka: never blinded) trial (ICT-107). You might want to rethink that. Or maybe it suits you just fine.

Furthermore, you don't know if the results of the DCVax-L trial will be confounded or not when they compare arms. If you do, you have insider information.

Furthermore, it is randomized at 2.34:1, albeit, not perfect, but I suppose regulators already know that.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News